Singapore - English - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - metformin hydrochloride + 0.5% magnesium stearate; saxagliptin hydrochloride anhydrous 5.58mg eqv saxagliptin - tablet, film coated, extended release - 1000mg - metformin hydrochloride + 0.5% magnesium stearate 1000mg; saxagliptin hydrochloride anhydrous 5.58mg eqv saxagliptin 5.0mg

Singapore - English - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - metformin hydrochloride + 0.5% magnesium stearate; saxagliptin hydrochloride anhydrous 5.58mg eqv saxagliptin - tablet, film coated, extended release - 500mg - metformin hydrochloride + 0.5% magnesium stearate 500mg; saxagliptin hydrochloride anhydrous 5.58mg eqv saxagliptin 5.0mg

Singapore - English - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - saxagliptin hydrochloride (anhydrous) 2.79 mg eqv saxagliptin - tablet, film coated - 2.5 mg - saxagliptin hydrochloride (anhydrous) 2.79 mg eqv saxagliptin 2.5 mg

Singapore - English - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - saxagliptin hydrochloride (anhydrous) 5.58 mg eqv saxagliptin - tablet, film coated - 5 mg - saxagliptin hydrochloride (anhydrous) 5.58 mg eqv saxagliptin 5 mg

Singapore - English - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - budesonide; formoterol fumarate dihydrate - powder, metered - 160 mcg/dose - budesonide 160 mcg/dose; formoterol fumarate dihydrate 4.5 mcg/dose

Singapore - English - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - budesonide; formoterol fumarate dihydrate - powder, metered - 80 mcg/dose - budesonide 80 mcg/dose; formoterol fumarate dihydrate 4.5 mcg/dose

Australia - English - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - water for injections -

European Union - English - EMA (European Medicines Agency)

astrazeneca ab - selumetinib sulfate - neurofibromatosis 1 - antineoplastic agents - koselugo as monotherapy is indicated for the treatment of symptomatic, inoperable plexiform neurofibromas (pn) in paediatric patients with neurofibromatosis type 1 (nf1) aged 3 years and above

European Union - English - EMA (European Medicines Agency)

astrazeneca ab - a/darwin/9/2021 (h3n2) - like strain (a/norway/16606/2021, medi 355293) / a/victoria/2570/2019 (h1n1)pdm09 - like strain (a/victoria/1/2020, medi 340505) / b/austria/1359417/2021 - like strain (b/austria/1359417/2021, medi 355292) / b/phuket/3073/2013 - like strain (b/phuket/3073/2013, medi 306444) - influenza, human - influenza vaccines, influenza, live attenuated - prophylaxis of influenza in children and adolescents from 24 months to less than 18 years of age. the use of fluenz tetra should be based on official recommendations.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

astrazeneca sdn. bhd. - tixagevimab; cilgavimab -